Pharmanutra S.p.A. (PHN.MI)
EUR 53.2
(-1.48%)
EUR 53.2
(-1.48%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.33 EUR | -14.74% |
| 2022 | 1.56 EUR | 9.86% |
| 2021 | 1.42 EUR | -2.07% |
| 2020 | 1.45 EUR | 66.67% |
| 2019 | 0.87 EUR | -1.14% |
| 2018 | 0.88 EUR | 41.94% |
| 2017 | 0.62 EUR | 12.73% |
| 2016 | 0.55 EUR | 48.65% |
| 2015 | 0.37 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.27 EUR | -15.63% |
| 2024 Q2 | 0.65 EUR | 140.74% |
| 2023 Q4 | 0.32 EUR | 23.08% |
| 2023 FY | - EUR | -14.74% |
| 2023 Q1 | 0.56 EUR | 143.48% |
| 2023 Q2 | 0.19 EUR | -66.07% |
| 2023 Q3 | 0.26 EUR | 36.84% |
| 2022 FY | - EUR | 9.86% |
| 2022 Q4 | 0.23 EUR | -52.08% |
| 2022 Q3 | 0.48 EUR | -2.04% |
| 2022 Q2 | 0.49 EUR | 36.11% |
| 2022 Q1 | 0.36 EUR | 20.0% |
| 2021 Q4 | 0.30 EUR | -25.0% |
| 2021 Q3 | 0.40 EUR | -14.89% |
| 2021 FY | - EUR | -2.07% |
| 2021 Q1 | 0.26 EUR | -3.7% |
| 2021 Q2 | 0.47 EUR | 80.77% |
| 2020 Q4 | 0.27 EUR | 50.0% |
| 2020 FY | - EUR | 66.67% |
| 2020 Q1 | 0.27 EUR | 0.0% |
| 2020 Q2 | 0.74 EUR | 174.07% |
| 2020 Q3 | 0.18 EUR | -75.68% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q4 | 0.27 EUR | 0.0% |
| 2019 FY | - EUR | -1.14% |
| 2019 Q1 | 0.21 EUR | -19.23% |
| 2019 Q2 | 0.21 EUR | 0.0% |
| 2018 Q1 | 0.18 EUR | 12.5% |
| 2018 FY | - EUR | 41.94% |
| 2018 Q4 | 0.26 EUR | 0.0% |
| 2018 Q3 | 0.26 EUR | 44.44% |
| 2018 Q2 | 0.18 EUR | 0.0% |
| 2017 FY | - EUR | 12.73% |
| 2017 Q1 | 0.18 EUR | 63.64% |
| 2017 Q2 | 0.18 EUR | 0.0% |
| 2017 Q3 | 0.16 EUR | -11.11% |
| 2017 Q4 | 0.16 EUR | 0.0% |
| 2016 Q1 | 0.14 EUR | 0.0% |
| 2016 Q2 | 0.14 EUR | -1.41% |
| 2016 Q3 | 0.12 EUR | -12.86% |
| 2016 Q4 | 0.11 EUR | -9.84% |
| 2016 FY | - EUR | 48.65% |
| 2015 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|